Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piazza

Showing results (351-360 of 402) with videos related to

Pageof 41
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2012
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activityJason D Whitt, Nan Li, Heather N Tinsley, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2022
A novel sulindac derivative protects against oxidative damage by a cyclooxygenase-independent mechanismShailaja Kesaraju Allani, Ramanjaneyulu Rayala, Oscar Rivera, et al.
Cancer Research|May 20, 2016
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSangbin Lim, Hao Liu, Luciana Madeira da Silva, et al.
Neurosurgical Focus|November 3, 2011
Traumatic brain injury in pediatric patients: evidence for the effectiveness of decompressive surgeryGeoffrey Appelboom, Stephen D Zoller, Matthew A Piazza, et al.
Frontiers in Pharmacology|December 23, 2021
Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate CancerTaraswi Mitra Ghosh, Jason White, Joshua Davis, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Journal for Immunotherapy of Cancer|July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapyNada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
Plos One|June 14, 2013
Identification of class I HLA T cell control epitopes for West Nile virusSaghar Kaabinejadian, Paolo A Piazza, Curtis P McMurtrey, et al.
Aging|January 13, 2017
Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in <i>Saccharomyces cerevisiae</i>Gregory Tombline, Jonathan I Millen, Bogdan Polevoda, et al.
Pageof 41

Showing results (351-360 of 402) with videos related to

Sort By:
Pageof 41
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2012
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activityJason D Whitt, Nan Li, Heather N Tinsley, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2022
A novel sulindac derivative protects against oxidative damage by a cyclooxygenase-independent mechanismShailaja Kesaraju Allani, Ramanjaneyulu Rayala, Oscar Rivera, et al.
Cancer Research|May 20, 2016
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSangbin Lim, Hao Liu, Luciana Madeira da Silva, et al.
Neurosurgical Focus|November 3, 2011
Traumatic brain injury in pediatric patients: evidence for the effectiveness of decompressive surgeryGeoffrey Appelboom, Stephen D Zoller, Matthew A Piazza, et al.
Frontiers in Pharmacology|December 23, 2021
Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate CancerTaraswi Mitra Ghosh, Jason White, Joshua Davis, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Journal for Immunotherapy of Cancer|July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapyNada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
Plos One|June 14, 2013
Identification of class I HLA T cell control epitopes for West Nile virusSaghar Kaabinejadian, Paolo A Piazza, Curtis P McMurtrey, et al.
Aging|January 13, 2017
Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in <i>Saccharomyces cerevisiae</i>Gregory Tombline, Jonathan I Millen, Bogdan Polevoda, et al.
Pageof 41